DexCom, Inc. DC4.F Stock
DexCom, Inc. Price Chart
DexCom, Inc. DC4.F Financial and Trading Overview
DexCom, Inc. stock price | 130 EUR |
Previous Close | 118.78 EUR |
Open | 119.18 EUR |
Bid | 119.6 EUR x 20000 |
Ask | 120 EUR x 20000 |
Day's Range | 119.18 - 119.18 EUR |
52 Week Range | 64.71 - 124.42 EUR |
Volume | 110 EUR |
Avg. Volume | 13 EUR |
Market Cap | 46.67B EUR |
Beta (5Y Monthly) | 1.144718 |
PE Ratio (TTM) | 172.72464 |
EPS (TTM) | 1.21 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 530.6 EUR |
DC4.F Valuation Measures
Enterprise Value | 44.77B EUR |
Trailing P/E | 172.72464 |
Forward P/E | 33.76204 |
PEG Ratio (5 yr expected) | 13.32 |
Price/Sales (ttm) | 15.440957 |
Price/Book (mrq) | 20.68738 |
Enterprise Value/Revenue | 14.811 |
Enterprise Value/EBITDA | 82.686 |
Trading Information
DexCom, Inc. Stock Price History
Beta (5Y Monthly) | 1.144718 |
52-Week Change | 80.15% |
S&P500 52-Week Change | 20.43% |
52 Week High | 124.42 EUR |
52 Week Low | 64.71 EUR |
50-Day Moving Average | 108.91 EUR |
200-Day Moving Average | 103.87 EUR |
DC4.F Share Statistics
Avg. Volume (3 month) | 13 EUR |
Avg. Daily Volume (10-Days) | 13 EUR |
Shares Outstanding | 387.64M |
Float | 384.55M |
Short Ratio | N/A |
% Held by Insiders | 0.40% |
% Held by Institutions | 100.06% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 4:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 9.67% |
Operating Margin (ttm) | 13.13% |
Gross Margin | 64.43% |
EBITDA Margin | 17.91% |
Management Effectiveness
Return on Assets (ttm) | 4.69% |
Return on Equity (ttm) | 13.22% |
Income Statement
Revenue (ttm) | 3.02B EUR |
Revenue Per Share (ttm) | 7.77 EUR |
Quarterly Revenue Growth (yoy) | 17.89% |
Gross Profit (ttm) | 1.88B EUR |
EBITDA | 541.4M EUR |
Net Income Avi to Common (ttm) | 292.5M EUR |
Diluted EPS (ttm) | 0.69 |
Quarterly Earnings Growth (yoy) | -50.10% |
Balance Sheet
Total Cash (mrq) | 2.57B EUR |
Total Cash Per Share (mrq) | 6.62 EUR |
Total Debt (mrq) | 2.14B EUR |
Total Debt/Equity (mrq) | 95.96 EUR |
Current Ratio (mrq) | 2.02 |
Book Value Per Share (mrq) | 5.761 |
Cash Flow Statement
Operating Cash Flow (ttm) | 753.9M EUR |
Levered Free Cash Flow (ttm) | 429.06M EUR |
Profile of DexCom, Inc.
Country | Germany |
State | CA |
City | San Diego |
Address | 6340 Sequence Drive |
ZIP | 92121 |
Phone | 858 200 0200 |
Website | https://www.dexcom.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 7500 |
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices for specific and permitted use cases, including non-medical device applications, medical device data analysis, integrated continuous glucose monitoring systems (iCGM) secondary display alarms, active patient monitoring, and treatment decisions; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Q&A For DexCom, Inc. Stock
What is a current DC4.F stock price?
DexCom, Inc. DC4.F stock price today per share is 130 EUR.
How to purchase DexCom, Inc. stock?
You can buy DC4.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for DexCom, Inc.?
The stock symbol or ticker of DexCom, Inc. is DC4.F.
Which industry does the DexCom, Inc. company belong to?
The DexCom, Inc. industry is Medical Devices.
How many shares does DexCom, Inc. have in circulation?
The max supply of DexCom, Inc. shares is 385.52M.
What is DexCom, Inc. Price to Earnings Ratio (PE Ratio)?
DexCom, Inc. PE Ratio is 107.43801000 now.
What was DexCom, Inc. earnings per share over the trailing 12 months (TTM)?
DexCom, Inc. EPS is 1.21 EUR over the trailing 12 months.
Which sector does the DexCom, Inc. company belong to?
The DexCom, Inc. sector is Healthcare.